about
Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients.Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine.Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced CardiotoxicityCardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to TrastuzumabLow doses of Bisphenol A have pro-inflammatory and pro-oxidant effects, stimulate lipid peroxidation and increase the cardiotoxicity of Doxorubicin in cardiomyoblastsThe Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
P50
Q37131070-98E3A8BD-EEBD-45E5-ACE8-34C2C4B40714Q37397983-67572484-07C9-483A-96C7-1BCBEC9A757BQ38835359-8069338E-82FD-4E6F-AAE0-9EAC6561F2C2Q38835373-94504762-E445-4496-BB1E-A715761C9E06Q39468098-9BCAE99F-428C-4705-990B-4987C5E14FADQ46941129-56DFCDF6-FB7D-47AA-975B-046FCB71E6B0Q47568066-D18493F5-253C-4718-8ED3-2937B8560899Q50146298-2BE285E2-8645-4576-B9B5-535BA7DD4273Q52714655-B20E9FC1-90DB-472E-AF05-2C6D2F3C7C1EQ58738740-08277D69-0E3F-402A-AB3B-782ED798694DQ92498966-671E9464-0C37-44BF-95CB-609669D7B49FQ92570164-471B4D0E-5D34-4180-B03A-8A2AA317D2C3Q92812744-7CEA7971-3B8C-42D8-9A18-7A9F1473012B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Carmela Coppola
@en
Carmela Coppola
@nl
type
label
Carmela Coppola
@en
Carmela Coppola
@nl
prefLabel
Carmela Coppola
@en
Carmela Coppola
@nl
P31
P496
0000-0003-2943-8164